Medical News

RSS

Janssen seeks European marketing approval for combination of once-daily darunavir with cobicistat

Janssen-Cilag International NV, today announced it has submitted a Marketing Authorisation Application to the European Medicines Agency seeking approval for a once-daily single tablet fixed-dose antiretroviral combination product containing darunavir, a protease inhibitor developed by Janssen, with cobicistat, a pharmacokinetic enhancer or boosting agent, developed by Gilead Sciences, Inc. for use in combination with other human immunodeficiency virus medicines.

15 Oct 2013

Study explores why girls in minority groups, low-income families don't get HPV vaccine

A new study explores why girls in minority groups and low-income families, who are most at risk for cervical cancer, may not be getting the human papillomavirus or HPV vaccine.

15 Oct 2013

Marketing and technical support cooperation for aqueous acrylic enteric system, Acryl-EZE®, launched by Colorcon and Evonik Industries

Colorcon Inc. and Evonik Industries AG have announced the signing of a cooperation agreement for the marketing and technical support of Acryl-EZE®, aqueous acrylic enteric system.

15 Oct 2013

Health law's success hinges on whether the goal of enrolling 7 million is met -- making outreach strategies key

News outlets examine the work of navigators and other efforts to enroll people without health insurance into new coverage under the health law.

15 Oct 2013

Acacia Pharma reports positive results from APD515 Phase II study for treatment of xerostomia

Acacia Pharma, a pharmaceutical company specialising in the development of drugs for supportive care, announces positive results from its Phase II study of APD515 for the treatment of xerostomia (dry mouth) in advanced cancer patients.

15 Oct 2013

immatics biotechnologies closes €34 million Series D financing round

immatics biotechnologies GmbH, a clinical-stage biopharmaceutical company developing advanced multi-peptide cancer vaccines that are active against cancer, today announced that it has closed a €34 million Series D financing round.

15 Oct 2013

Colorcon, Evonik partner to market and support Acryl-EZE aqueous acrylic enteric system

Colorcon and Evonik have announced the signing of a cooperation agreement for the market promotion and technical support of Acryl-EZE, aqueous acrylic enteric system.

15 Oct 2013

NSW Health agrees to install iMDsoft's MetaVision clinical information system throughout the state

iMDsoft, a leader in clinical information systems, announced that NSW Health has signed an agreement to install MetaVision throughout the state's adult, pediatric and neonatal ICU beds.

15 Oct 2013

12% of midlife women are satisfied with their body size, shows study

A new study of women ages 50 and older examines the 12.2 percent who say they are satisfied with their body size to unlock the secrets of body satisfaction.

15 Oct 2013

St. Jude Medical completes Nanostim acquisition; leadless pacemaker receives CE Mark approval

St. Jude Medical, Inc., a global medical device company, today announced the completion of its acquisition of Nanostim, Inc., a privately-owned developer of miniaturized, leadless pacemakers.

15 Oct 2013

Crown Bioscience enters into collaboration with Xstrahl for radiation biology research

Crown Bioscience, Inc., a leading global drug discovery and development service company, today announces that it has entered into a collaboration with Xstrahl Ltd, a leading designer and manufacturer of X-Ray solutions for radiation biology research.

From Xstrahl 15 Oct 2013

Tepnel Pharma Services uses Hologic’s Invader Plus technology to offer genotyping, CNV service

Tepnel Pharma Services, a division of Hologic, Inc., is now using Hologic’s proprietary Invader and Invader Plus technology as part of its Molecular Genetic Services offering, enabling it to offer customers a more cost effective and high throughput genotyping and copy number variation service.

From Hologic, Inc. 15 Oct 2013

Promising new type of cancer treatment to benefit more patients

More patients than ever stand to benefit from a promising new type of cancer treatment, after scientists compiled a library of molecules that can prime patients’ immune systems to fight a range of cancers including leukaemia, myeloma, lung cancer and skin cancer.

15 Oct 2013

Study evaluates economic cost of cancer across 27 countries of the EU

The first ever study to evaluate the economic cost of cancer across the 27 countries of the EU has found that the total cost of cancer in the EU in 2009 was €126 billion, with cancer in Germany, France, Italy, and the UK together accounting for just over two-thirds of this cost (€83 billion).

15 Oct 2013

State highlights: Md. submits plan to tie overhaul hospital charges to state's economy

A selection of health policy stories from Maryland, California, Missouri and Florida.

15 Oct 2013

Researchers to present latest findings in emergency medicine research at ACEP13-Scientific Assembly

Leading researchers in emergency medicine will present more than 400 studies during ACEP13-Scientific Assembly, the annual meeting of the American College of Emergency Physicians in Seattle, Washington.

15 Oct 2013

Asthma: The costs of meds and challenges of care

Although asthma can usually be controlled with prescription medications, being able to afford them requires good insurance or lots of disposable income.

15 Oct 2013

Rates of hospital-acquired bedsores not accurate tool for comparing hospital quality, says report

The data Medicare uses to publicly report hospital rates of patients developing pressure ulcers (or bedsores) is not an accurate source for comparing hospitals on how well they prevent the condition, says a new University of Michigan study.

15 Oct 2013

Viewpoints: Marketplaces' 'technical foibles' may keep young people from coming back; health law may be ushering in era of narrow networks

The encouraging view is that the overwhelming number of visitors to the site indicates high demand for insurance in the new system. That's critical, because the more people who participate, the better the system works. The danger is that the technical foibles since Oct. 1 will discourage people from coming back, particularly the young and healthy customers the system needs to keep rates reasonable. With some big deadlines approaching, the Obama administration needs to fix the bugs, and fast. People who need insurance from the federal marketplace have until mid-December to buy coverage that begins Jan. 1. If enrollment figures aren't robust by then, the new health-care system will have a problem even bigger than a frustrating Web (10/11).

15 Oct 2013

Multiple courses of prenatal corticosteroids did not increase risk of death for young children

Multiple courses of prenatal corticosteroids, compared with a single course, taken by pregnant women to help prevent preterm birth was associated with no increase or decrease in the risk of death or disability for their children at age 5, according to a study published by JAMA Pediatrics, a JAMA Network publication.

15 Oct 2013

Medical News

Janssen seeks European marketing approval for combination of once-daily darunavir with cobicistat

Study explores why girls in minority groups, low-income families don't get HPV vaccine

Marketing and technical support cooperation for aqueous acrylic enteric system, Acryl-EZE®, launched by Colorcon and Evonik Industries

Health law's success hinges on whether the goal of enrolling 7 million is met -- making outreach strategies key

Acacia Pharma reports positive results from APD515 Phase II study for treatment of xerostomia

immatics biotechnologies closes €34 million Series D financing round

Colorcon, Evonik partner to market and support Acryl-EZE aqueous acrylic enteric system

NSW Health agrees to install iMDsoft's MetaVision clinical information system throughout the state

12% of midlife women are satisfied with their body size, shows study

St. Jude Medical completes Nanostim acquisition; leadless pacemaker receives CE Mark approval

Crown Bioscience enters into collaboration with Xstrahl for radiation biology research

Tepnel Pharma Services uses Hologic’s Invader Plus technology to offer genotyping, CNV service

Promising new type of cancer treatment to benefit more patients

Study evaluates economic cost of cancer across 27 countries of the EU

State highlights: Md. submits plan to tie overhaul hospital charges to state's economy

Researchers to present latest findings in emergency medicine research at ACEP13-Scientific Assembly

Asthma: The costs of meds and challenges of care

Rates of hospital-acquired bedsores not accurate tool for comparing hospital quality, says report

Viewpoints: Marketplaces' 'technical foibles' may keep young people from coming back; health law may be ushering in era of narrow networks

Multiple courses of prenatal corticosteroids did not increase risk of death for young children

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News